Papers
2
Total Citations
206
H-Index
2
About
Dr. C. Ostheimer is a leading clinical researcher in radiation oncology, with a primary focus on stereotactic body radiotherapy (SBRT) for oligometastatic disease and early-stage lung cancer. Their most impactful contribution is spearheading the German Society for Radiation Oncology (DEGRO) SBRT database initiative, a landmark project that provides real-world patterns of care and outcome analysis. The flagship study from this initiative, analyzing SBRT for liver oligometastases across 474 patients with 623 metastases, has garnered 152 citations, establishing critical factors influencing local control and overall survival in this emerging treatment paradigm. Dr. Ostheimer also led a pivotal planning benchmark study for SBRT in early-stage non-small cell lung cancer (NSCLC), cited 54 times, which standardized treatment protocols across German centers. This work has directly shaped clinical guidelines and improved the precision of SBRT delivery. By bridging multi-institutional data with rigorous dosimetric analysis, Dr. Ostheimer’s research has been instrumental in validating SBRT as a definitive, non-invasive option for patients with limited metastatic spread, offering a powerful alternative to systemic therapy. Their contributions continue to drive evidence-based practice in modern radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2Planning benchmark study for SBRT of early stage NSCLC54 citations · 2017